Results 111 to 120 of about 18,364 (184)

Correction to: Exploring the association between sweet liking and treatment response to naltrexone in patients with alcohol use disorder. [PDF]

Int J Neuropsychopharmacol
europepmc   +1 more source

Pharmacists expand access to contingency management in patients with substance use disorders. [PDF]

Ment Health Clin
Salsman M, Colvard M, Beam C, Frey T, Rothbauer K, Eatmon C.   +5 more
europepmc   +1 more source

Health Plan Disenrollment and Mortality After Initiation of Medications for Opioid Use Disorder. [PDF]

JAMA Psychiatry
Nguyen AP, Binswanger IA, Narwaney KJ, Goodrich G, Christine PJ, Campbell CI, Xu S, Loree AM, Glanz JM.   +8 more
europepmc   +1 more source

Quantitative assessment of light discomfort thresholds in a patient with photoallodynia treated with topical naltrexone 0.01. [PDF]

Am J Ophthalmol Case Rep
Lixi F, Coco G, Calabresi V, Vitiello L, Corda C, Verdiglione M, Costa S, Giannaccare G.   +7 more
europepmc   +1 more source

The NOD (Naltrexone for Overdose Prevention) study protocol: a pilot randomized controlled trial of intramuscular naltrexone for opioid overdose prevention among people who use stimulants living with or at risk for HIV. [PDF]

Addict Sci Clin Pract
Appa A, Marti XL, Baral S, Shoptaw S, Bazazi AR, Spinelli MA, Glidden D, Gandhi M, Coffin P.   +8 more
europepmc   +1 more source

Reserpine-induced fibromyalgia model in female rats is a long-lasting painful condition masked by antinociceptive endogenous opioids. [PDF]

Front Pharmacol
Juárez-Núñez C, Segura-Chama P, Pizaña-Encarnación JM, Pellicer F, Granados-Soto V, Mercado F, Almanza A.   +6 more
europepmc   +1 more source

[Naltrexone].

Medicina clinica, 1987
openaire   +3 more sources

Pharmacotherapy for Alcohol Use Disorder: A Brief Review of Available Options and Their Integration With Lifestyle Medicine Approaches. [PDF]

Am J Lifestyle Med
Caples D, Srivastava S.
europepmc   +1 more source

Case report: the challenges of psychogenic polydipsia. [PDF]

Oxf Med Case Reports
Raha A, Mordekar A.
europepmc   +1 more source